PDF(Pubmed)
Abstract：
Percutaneous balloon mitral valvotomy (PBMV) is a good and preferred therapy choice over surgical commissurotomy for patients with rheumatic mitral stenosis (MS). However, interventional cardiologists must recognize that treating patients with rheumatic MS poses unique challenges for each patient, especially in special populations such as pregnant patients or patients with arrhythmias like atrial fibrillation (AF), which can complicate procedures. Based on information from observational studies, PBMV may be a safe and efficient treatment for improving outcomes in MS women who do not have substantial subvalve illness in a specific demographic. A successful PBMV helps to tolerate hemodynamic changes during pregnancy and dramatically reduces mortality. However, there is a paucity of studies on women with poor valve morphology who are not contraindicated, and it has to be seen if PBMV is used in these situations during pregnancy. Conversely, AF leads to a lower PBMV success rate as well as worse long-term and in-hospital outcomes.
摘要：
对于风湿性二尖瓣狭窄（MS）患者，经皮球囊二尖瓣切开术（PBMV）是一种较好的首选治疗方法。然而,介入心脏病学家必须认识到，治疗风湿性MS患者对每个患者都有独特的挑战，特别是在特殊人群中，如怀孕患者或患有心律失常如心房颤动（AF）的患者，这会使程序复杂化。根据观测研究的信息，PBMV可能是一种安全有效的治疗方法，可以改善特定人群中没有实质性瓣膜下疾病的MS女性的预后。成功的PBMV有助于耐受妊娠期间的血液动力学变化，并显着降低死亡率。然而,对瓣膜形态差的女性没有禁忌的研究很少，并且必须观察在怀孕期间是否在这些情况下使用PBMV。相反，AF导致较低的PBMV成功率以及更差的长期和住院结果。
